当前位置:首页 - 行情中心 - 金石亚药(300434) - 财务分析 - 利润表

金石亚药

(300434)

  

流通市值:27.27亿  总市值:32.02亿
流通股本:3.42亿   总股本:4.02亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入291,494,123.061,102,354,866.43756,645,811.15521,930,079.53
营业收入291,494,123.061,102,354,866.43756,645,811.15521,930,079.53
二、营业总成本220,668,215.68966,461,177.06670,119,991.15454,037,885.74
营业成本115,818,296.44469,213,169.76337,593,894.03225,155,874.87
税金及附加5,155,483.7721,571,892.3513,289,533.39,391,663.23
销售费用49,853,310.91250,895,830.43172,290,852.34121,141,392.53
管理费用39,415,502.92179,246,441.41118,903,992.7580,784,582.5
研发费用11,012,429.6449,999,051.3730,034,741.219,863,344.15
财务费用-586,808-4,465,208.26-1,993,022.47-2,298,971.54
其中:利息费用290,322.691,319,956.21,008,743.17706,334.7
其中:利息收入803,388.875,338,914.993,366,004.222,809,175.47
加:公允价值变动收益1,417,319.452,998,847.221,625,273.55679,867.08
加:投资收益-3,330,217.86-14,353,161.32-8,030,294.51-5,479,602.64
资产处置收益44,491.19-20,095.666,163.416,117.67
资产减值损失(新)81,700.74-3,969,918.77-852,265.13-863,901.45
信用减值损失(新)1,170,657.79-4,270,494.2-3,167,062.79-3,192,105.99
其他收益5,105,234.0814,195,909.2812,925,282.96,268,927.33
营业利润平衡项目0000
四、营业利润75,315,092.77130,474,775.9289,032,917.4365,311,495.79
加:营业外收入35,608.341,738,845.961,159,656.931,098,735.82
减:营业外支出281,320.599,557,083.947,495,058.725,105,508.6
利润总额平衡项目0000
五、利润总额75,069,380.52122,656,537.9482,697,515.6461,304,723.01
减:所得税费用12,975,579.6534,096,662.4626,816,959.723,330,120.14
六、净利润62,093,800.8788,559,875.4855,880,555.9437,974,602.87
持续经营净利润62,093,800.8788,559,875.4855,880,555.9437,974,602.87
归属于母公司股东的净利润62,851,306.7691,761,833.858,129,095.9639,202,246.68
少数股东损益-757,505.89-3,201,958.32-2,248,540.02-1,227,643.81
(一)基本每股收益0.160.230.140.1
(二)稀释每股收益0.160.230.140.1
九、综合收益总额62,093,800.8788,559,875.4855,880,555.9437,974,602.87
归属于母公司股东的综合收益总额62,851,306.7691,761,833.858,129,095.9639,202,246.68
归属于少数股东的综合收益总额-757,505.89-3,201,958.32-2,248,540.02-1,227,643.81
公告日期2025-04-252025-04-252024-10-242024-08-29
审计意见(境内)标准无保留意见
TOP↑